Letrozole (for Ovulation Induction)

Treatment for Polycystic Ovary Syndrome

Typical Dosage: 2.5-7.5mg daily for 5 days per cycle

Effectiveness
70%
Safety Score
60%
Clinical Trials
28
Participants
12K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
2.5-7.5mg daily for 5 days per cycle
Time to Effect
1-2 menstrual cycles
Treatment Duration
3-6 cycles
Evidence Quality
HIGH
Number Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
30(Treat 30 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$750
Side Effect Mgmt:$50
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$1,428
Comparison vs Clomiphene Citrate
Cost Difference
$0/year
Same cost
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Letrozole (for Ovulation Induction) Outcomes

for Polycystic Ovary Syndrome

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+70%
Common Side Effects
Hot flashes
+25%
Headache
+15%
Fatigue
+10%
Dizziness
+7%
Multiple gestation
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
6 active trials recruiting for Letrozole (for Ovulation Induction) in Polycystic Ovary Syndrome

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone

NCT06507332RECRUITINGNA
View Study
64 participants
INTERVENTIONAL
Cairo, Egypt
Started: Mar 1, 2024

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

NCT06405243NOT YET RECRUITINGPHASE3
View Study
100 participants
INTERVENTIONAL
Banī Suwayf, Egypt +1 more
Started: Jun 30, 2024

Letrozole Extended vs Traditional Therapy for Ovulation Induction in Women With PCOS (PROLEx-PCOS)

NCT07159880RECRUITINGNA
View Study
20 participants
INTERVENTIONAL
São Paulo, Brazil
Started: Sep 1, 2025

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

NCT06813118RECRUITINGPHASE1
View Study
42 participants
INTERVENTIONAL
Rawalpindi, Pakistan
Started: Jun 7, 2024

Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients

NCT06861803NOT YET RECRUITING
View Study
138 participants
OBSERVATIONAL
Cairo, Egypt
Started: Apr 1, 2025

Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS

NCT06793904RECRUITINGNA
View Study
122 participants
INTERVENTIONAL
Cairo, Egypt
Started: Feb 1, 2025
Completed Clinical Trials
13 completed trials for Letrozole (for Ovulation Induction) in Polycystic Ovary Syndrome

Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction

NCT07168837COMPLETEDNA
View Study
100 participants
INTERVENTIONAL
Asyut, Egypt
Started: Jan 10, 2023

Letrozole Dose Increments in PCOS Patients Resistant to Letrozole

NCT06403488COMPLETEDPHASE3
View Study
102 participants
INTERVENTIONAL
Banī Suwayf, Egypt +1 more
Started: Oct 1, 2023

The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)

NCT01577017COMPLETEDPHASE3
View Study
150 participants
INTERVENTIONAL
Started: May 1, 2008

Letrozole Step up Protocol for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome

NCT07143682COMPLETEDPHASE3
View Study
70 participants
INTERVENTIONAL
Dhaka, Bangladesh
Started: Jan 8, 2023

Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol

NCT06367712COMPLETEDPHASE1
View Study
132 participants
INTERVENTIONAL
Cairo, Egypt
Started: Nov 10, 2022

Letrozole Versus Clomifene Citrate for Ovulation Induction

NCT00478504COMPLETEDPHASE4
View Study
159 participants
INTERVENTIONAL
Derby, United Kingdom
Started: May 1, 2007

Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.

NCT00956267COMPLETEDNA
View Study
260 participants
INTERVENTIONAL
Al Mansurah, Egypt
Started: Aug 1, 2006

Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome

NCT05702957COMPLETEDPHASE2, PHASE3
View Study
220 participants
INTERVENTIONAL
Lahore, Pakistan
Started: Sep 1, 2016

Ovulation Induction in Clomiphene Citrate Resistant PCO Women

NCT02341703COMPLETEDEARLY_PHASE1
View Study
100 participants
INTERVENTIONAL
Cairo, Egypt
Started: Feb 1, 2015

Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole

NCT03440359COMPLETEDPHASE2, PHASE3
View Study
52 participants
INTERVENTIONAL
Norfolk, United States
Started: Jul 6, 2012

Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome

NCT00911313COMPLETEDNA
View Study
250 participants
INTERVENTIONAL
Al Mansurah, Egypt
Started: Jun 1, 2006

Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS

NCT01909141COMPLETEDEARLY_PHASE1
View Study
100 participants
INTERVENTIONAL
Cairo, Egypt
Started: Aug 1, 2013

Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS Women

NCT06486870COMPLETEDPHASE3
View Study
183 participants
INTERVENTIONAL
Cairo, Egypt
Started: Jan 1, 2020
Showing 20 of 29 total trials